Ranbaxy Laboratories to market Daiichi Sankyo’s Sevikarin in Romania – Economic Times

NEW DELHI: Ranbaxy Laboratories will market Daiichi Sankyo’s antihypertensive drug Sevikarin in Romania expanding its hybrid model strategy to the European country. The Indian company will sell Sevikar, a combination of amlodipine besylate and …

Leave a Reply

Your email address will not be published. Required fields are marked *